In 2021, her laboratory partnered with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research.

The humanized mouse model market is set to grow by USD 61.6M from 2024-2029, with a CAGR of 6.7%. Key drivers include personalized medicine and genetic engineering advances. The report offers a ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...

Immunotherapy employs patients' own immune systems to fight cancer, and it has shown itself to be an effective treatment in ...

June 13, 2025 Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics.

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.

Biocytogen also offers immune-humanized mouse models (e.g., huPBMC-B-NDG, huHSC-B-NDG, huHSC-B-NDG hIL15, and huPBMC-B-NDG MHC I/II DKO plus), transgenic mice, and immunodeficient strains to ...

In mouse models, CT-2A cells were implanted in C57BL/6 mice and IOMM-Lee in MHC I/II double knockout mice humanized with peripheral blood mononuclear cells (PBMCs). Results: PBAE NP delivery of GFP ...

The first humanized mice were created in the 1980s to model human HIV infection and the human immune response to HIV. Humanized mice were, and have been created since, by injecting immunodeficient ...